Stock Screener App

無料 -

インストール

Medical Devices

3.46

2.26% -0.08

Perspective Therapeutics Inc (CATX)

概要ニュース株価時系列ディスカッション予測株式分割

Perspective Therapeutics Inc (CATX) 最新ニュース

What technical models suggest about Perspective Therapeutics Inc.’s comeback2025 Volume Leaders & Daily Price Action Insights - Newser

Is Perspective Therapeutics Inc. stock entering bullish territoryPortfolio Return Summary & Weekly Stock Breakout Alerts - Newser

Chart overlay techniques for tracking Perspective Therapeutics Inc.July 2025 Closing Moves & Fast Gain Stock Trading Tips - Newser

Leading vs lagging indicators on Perspective Therapeutics Inc. performanceJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - Newser

How to use a screener to detect Perspective Therapeutics Inc. breakoutsJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser

Risk vs reward if holding onto Perspective Therapeutics Inc.Trade Performance Summary & Precise Buy Zone Tips - Newser

Perspective Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Reactions & Momentum Based Trading Ideas - Newser

Can volume confirm reversal in Perspective Therapeutics Inc.2025 Major Catalysts & Pattern Based Trade Signal System - Newser

What indicators show strength in Perspective Therapeutics Inc.2025 EndofYear Setup & Safe Capital Investment Plans - Newser

Applying chart zones and confluence areas to Perspective Therapeutics Inc.July 2025 Analyst Calls & Community Verified Swing Trade Signals - Newser

Perspective Therapeutics Announces Chief Financial Officer Changes - MarketScreener

Perspective Therapeutics Names Joel Sendek as CFO - MarketScreener

Perspective Therapeutics Appoints Joel Sendek as CFO - TipRanks

Perspective Therapeutics' Strategic Leadership Shift: How CFO Joel Sendek Could Ignite Financial and Operational Momentum - AInvest

Perspective Therapeutics' Strategic Leadership Move and Its Implications for Biotech Growth - AInvest

Perspective Therapeutics Appoints Biotech Veteran Joel Sendek as Chief Financial Officer - GlobeNewswire

Former Wall Street All-Star Who Raised $2.5B: Perspective Therapeutics Lands Biotech Finance Veteran as CFO - Stock Titan

Smart tools for monitoring Perspective Therapeutics Inc.’s price actionEntry Point & Long-Term Safe Return Strategies - Newser

Aug EndMonth: Can Perspective Therapeutics Inc. deliver alphaJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - khodrobank.com

Is Perspective Therapeutics Inc. being accumulated by smart moneyEarnings Miss & Short-Term Swing Trade Alerts - خودرو بانک

Building trade automation scripts for Perspective Therapeutics Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - Newser

Will Perspective Therapeutics Inc. outperform the marketEarnings Performance Report & Free Real-Time Market Sentiment Alerts - Newser

Perspective Therapeutics shares fall 1.02% after-hours following appointment of Maya Martinez-Davis to the Board of Directors. - AInvest

How does Perspective Therapeutics Inc. score in quality rankingsWeekly Stock Summary & AI Enhanced Trading Signals - خودرو بانک

Published on: 2025-09-03 09:07:22 - Newser

What institutional flow reveals about Perspective Therapeutics Inc.July 2025 Selloffs & Low Drawdown Investment Strategies - Newser

Perspective Therapeutics Appoints Maya Martinez-Davis to Board - TipRanks

Analyzing drawdowns of Perspective Therapeutics Inc. with statistical tools2025 Year in Review & Real-Time Stock Entry Alerts - Newser

Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors. - AInvest

Perspective Therapeutics appoints Maya Martinez-Davis as independent director. - AInvest

Perspective Therapeutics Appoints Maya Martinez-Davis to Board, Boosting Oncology Expertise - AInvest

Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors - MarketScreener

GSK US Commercial President Maya Martinez-Davis Joins Perspective Therapeutics' Board of Directors - Stock Titan

Published on: 2025-09-03 04:22:19 - Newser

Custom strategy builders for tracking Perspective Therapeutics Inc.July 2025 Selloffs & Weekly High Return Stock Forecasts - Newser

Analyst Downgrade: How does Perspective Therapeutics Inc. score in quality rankingsWeekly Stock Summary & Free Technical Confirmation Trade Alerts - خودرو بانک

Published on: 2025-09-03 01:26:42 - Newser

ETF Watch: Does Perspective Therapeutics Inc. stock have upside surprise potentialJuly 2025 Technicals & Reliable Price Breakout Alerts - خودرو بانک

Using fundamentals and technicals on Perspective Therapeutics Inc.Quarterly Portfolio Review & Daily Momentum Trading Reports - Newser

Is Perspective Therapeutics Inc. gaining market shareEarnings Risk Report & Daily Profit Focused Stock Screening - خودرو بانک

Perspective Therapeutics Updates on Radiopharmaceutical Advancements - TipRanks

Is a relief rally coming for Perspective Therapeutics Inc. holdersMarket Growth Report & Community Consensus Picks - Newser

Can Perspective Therapeutics Inc. deliver alphaCPI Data & Weekly High Return Forecasts - خودرو بانک

Update Recap: Is Perspective Therapeutics Inc. gaining market share2025 Fundamental Recap & Long-Term Investment Growth Plans - خودرو بانک

Does Perspective Therapeutics Inc. stock reflect fundamentalsWeekly Profit Summary & Daily Growth Stock Tips - خودرو بانک

Perspective Therapeutics Inc. Trading Near Value Zone — Recovery Ahead getLinesFromResByArray error: size == 0 - 강소기업뉴스

Perspective Therapeutics Inc. Volume Confirms Breakout — Analysts Bullish getLinesFromResByArray error: size == 0 - 강소기업뉴스

How institutional ownership impacts Perspective Therapeutics Inc. stockWeekly Investment Summary & Accurate Buy Signal Alerts - Newser

STE

$245.30

0.78%

PODD

$348.43

0.57%

PHG

$27.93

0.72%

DXCM

$80.51

0.31%

GEHC

$75.73

2.17%

EW

$80.94

0.02%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | ロイターで開く